HR Execs on the Move

C4 Therapeutics

www.c4therapeutics.com

 
C4 Therapeutics is pioneering a new class of drugs. C4`s technology platform produces small molecule drugs that harness machinery already present in cells to selectively target disease-relevant proteins for degradation. Our approach has the potential to address a broad range of diseases including cancer, infectious disease, and autoimmune disorders.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Melissa Epstein
Associate Director, Total Rewards Profile
Kelly Schick
Chief People Officer Profile
William McKee
Interim Chief Financial Officer Profile
Lauren White
Chief Financial Officer Profile
Krissy Zambouras
Director, Human Resources Profile

Similar Companies

IFM Therapeutics

At IFM Therapeutics, LLC, we work to improve the lives of patients with inflammatory disorders and cancer by developing transformative medicines that precisely target the innate immune system, the body`s first line of immunological response and an essential component of immune function.

Alphora Research Inc

Alphora Research Inc is a Mississauga, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Advantage Care Services

Advantage Care Services is a Asheville, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nova Analytics Corporation

Nova Analytics Corporation is a Woburn, MA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Tao Life Sciences

TAO Life Sciences invests in and develops early stage medical innovations. Working closely with physicians and researchers from universities and companies, TAO Life Sciences takes new concepts and turns them into reality. TAO Life Sciences is building a pipeline of promising medical device and life science innovations that will impact global healthcare markets and make a significant difference in people's lives. TAO Life Sciences applies its expertise to develop prototypes, demonstrate clinical proof of concept, and secure financial exits for our innovations. We bring design engineering, scientific direction, and business and legal strategy to clinicians' and researchers' new design concepts. In doing so, we have built a diversified pipeline of medical device technologies with significant commercial potential. The Company's principals have successfully brought medical device, diagnostic, therapeutic and other products to market over the past twenty years.